The upregulated PD-L1 expression in osteosarcoma, lung cancer, and prostate cancer in response to DSB required the activation of STAT1/3–IRF1 signaling pathway by ATM/ATR/Chk1 kinases [103]. Here, IRF1 is linked to lung carcinoma.